Cargando…

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine

Studies on gene expression in response to therapy have led to the discovery of pharmacogenomics biomarkers and advances in precision medicine. Whole transcriptome sequencing (RNA-seq) is an emerging tool for profiling gene expression and has received wide adoption in the biomedical research communit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Joshua, Gong, Binsheng, Wu, Leihong, Thakkar, Shraddha, Hong, Huixiao, Tong, Weida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810084/ https://www.ncbi.nlm.nih.gov/pubmed/26999190 http://dx.doi.org/10.3390/pharmaceutics8010008

Ejemplares similares

The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
por: Xu, Joshua, et al.
Publicado: (2016)

FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology
por: Li, Dan, et al.
Publicado: (2021)

Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs
por: Hong, Huixiao, et al.
Publicado: (2017)

Transcriptomic profiling of rat liver samples in a comprehensive study design by RNA-Seq
por: Gong, Binsheng, et al.
Publicado: (2014)

RNA-SeQC: RNA-seq metrics for quality control and process optimization
por: DeLuca, David S., et al.
Publicado: (2012)

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
por: Wu, Leihong, et al.
Publicado: (2019)

The SEQC2 epigenomics quality control (EpiQC) study
por: Foox, Jonathan, et al.
Publicado: (2021)

Author Correction: The SEQC2 epigenomics quality control (EpiQC) study
por: Foox, Jonathan, et al.
Publicado: (2021)

Direct comparison of performance of single nucleotide variant calling in human genome with alignment-based and assembly-based approaches
por: Wu, Leihong, et al.
Publicado: (2017)

Alignment of Short Reads: A Crucial Step for Application of Next-Generation Sequencing Data in Precision Medicine
por: Ye, Hao, et al.
Publicado: (2015)

An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era
por: Su, Zhenqiang, et al.
Publicado: (2014)

In memoriam Dr. Josep Maria Queraltó, esteemed member of the SEQC(ML) for 35 years
por: Board of Directors of the Spanish Society of Laboratory Medicine
Publicado: (2020)

Prenatal screening and diagnosis of genetic abnormalities: SEGO, SEQC(ML), AEDP consensus recommendations
por: Prieto, Belén, et al.
Publicado: (2020)

Challenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision Medicine
por: Xiao, Wenming, et al.
Publicado: (2016)

ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research -- an update
por: Xu, Joshua, et al.
Publicado: (2010)

Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies
por: Gong, Binsheng, et al.
Publicado: (2022)

Classifying Free Texts Into Predefined Sections Using AI in Regulatory Documents: A Case Study with Drug Labeling Documents
por: Gray, Magnus, et al.
Publicado: (2023)

Cross-platform ultradeep transcriptomic profiling of human reference RNA samples by RNA-Seq
por: Xu, Joshua, et al.
Publicado: (2014)

Recommendations for the measurement of sexual steroids in clinical practice. A position statement of SEQC(ML)/SEEN/SEEP
por: Casals, Gregori, et al.
Publicado: (2023)

Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents
por: Ng, Hui Wen, et al.
Publicado: (2018)

Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury
por: Li, Ting, et al.
Publicado: (2020)

DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
por: Li, Ting, et al.
Publicado: (2021)

Corrigendum: DeepCarc: Deep learning-powered carcinogenicity prediction using model-level representation
por: Li, Ting, et al.
Publicado: (2022)

Cribado y diagnóstico prenatal de anomalías genéticas: recomendaciones de consenso SEGO, SEQC(ML), AEDP
por: Prieto-García, Belén, et al.
Publicado: (2020)

State of affairs and future challenges in laboratory medicine in Spain: an analysis of the Spanish Society of Laboratory Medicine (SEQC(ML))
por: Caballé, Imma, et al.
Publicado: (2023)

Patient‐led research and Advocacy Efforts
por: Tsimicalis, Argerie, et al.
Publicado: (2022)

Evaluation of Bioinformatics Approaches for Next-Generation Sequencing Analysis of microRNAs with a Toxicogenomics Study Design
por: Bisgin, Halil, et al.
Publicado: (2018)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

A comprehensive rat transcriptome built from large scale RNA-seq-based annotation
por: Ji, Xiangjun, et al.
Publicado: (2020)

Adaptability of AI for safety evaluation in regulatory science: A case study of drug-induced liver injury
por: Connor, Skylar, et al.
Publicado: (2022)

Mining FDA drug labels using an unsupervised learning technique - topic modeling
por: Bisgin, Halil, et al.
Publicado: (2011)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control consortium
Publicado: (2014)

In memoriam Dr. Josep María Queraltó, destacado miembro de la SEQC(M) (L) desde hace 35 años
por: Junta Directiva de la Sociedad Española de Medicina del Laboratorio
Publicado: (2020)

Evaluation of 18 quality indicators from the external quality assurance preanalytical programme of the Spanish Society of Laboratory Medicine (SEQC(ML))
por: Caballero, Andrea, et al.
Publicado: (2022)

Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
por: Li, Dan, et al.
Publicado: (2020)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

DLI-IT: a deep learning approach to drug label identification through image and text embedding
por: Liu, Xiangwen, et al.
Publicado: (2020)

NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies
por: Wu, Leihong, et al.
Publicado: (2022)

Medical Students and Youth-Led Efforts against Infodemic
por: Fakorede, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tem0mk2rho05mumk8u47o3rrnp